Atomoxetine Augmentation in a Case of Treatment Resistant Panic Disorder with Multiple Augments Failure: A Case Report
Clinical Psychopharmacology and Neuroscience
;
: 321-323, 2015.
Article
in English
| WPRIM
| ID: wpr-209618
ABSTRACT
Atomoxetine, a selective norepinephrine inhibitor, is effective in comorbid anxiety and attention deficit hyperactivity disorder, however its role in panic disorder is unknown. We are presenting a case of panic disorder, who initially partially responded to clonazepam. When clonazepam was added with sertraline, escitalopram, desvenlafaxin, she did not improve significantly until paroxetine was added. When clonazepam-paroxetine combination was added with propranolol, etizolam, olanzepine, risperidone and amisulpride the symptom remission did not occur until a trial of Atomoxetine was done.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Anxiety
/
Panic
/
Propranolol
/
Attention Deficit Disorder with Hyperactivity
/
Citalopram
/
Norepinephrine
/
Panic Disorder
/
Clonazepam
/
Paroxetine
/
Risperidone
Language:
English
Journal:
Clinical Psychopharmacology and Neuroscience
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS